The Novel Opioid Control Act of 2023 aims to address the opioid crisis in the United States. The bill focuses on regulating new synthetic opioids to prevent their abuse and trafficking. It proposes stricter controls on the production, distribution, and prescribing of these novel opioids. Additionally, the bill includes measures to enhance monitoring and reporting requirements for healthcare providers to curb opioid misuse. Overall, the legislation seeks to strengthen regulations surrounding novel opioids to combat the ongoing opioid epidemic in the country.
2023-03-01: Filed
2023-03-06: Passed 1st Reading
2023-03-06: Ref to the Com on Health, if favorable, Judiciary 3, if favorable, Rules, Calendar, and Operations of the House
2023-03-14: Reptd Fav Com Substitute
2023-03-14: Re-ref Com On Judiciary 3
2023-03-14: Reptd Fav
2023-03-14: Re-ref Com On Rules, Calendar, and Operations of the House
2023-03-14: Reptd Fav
2023-03-14: Cal Pursuant Rule 36(b)
2023-03-14: Placed On Cal For 03/15/2023
2023-03-15: Passed 2nd Reading
2023-03-15: Passed 3rd Reading
2023-03-16: Regular Message Sent To Senate
2023-03-16: Regular Message Received From House
2023-03-16: Passed 1st Reading
2023-03-16: Ref To Com On Rules and Operations of the Senate
2023-06-20: Withdrawn From Com
2023-06-20: Re-ref to Judiciary. If fav, re-ref to Health Care. If fav, re-ref to Rules and Operations of the Senate
2023-06-22: Reptd Fav Com Substitute
2023-06-22: Com Substitute Adopted
2023-06-22: Re-ref Com On Health Care
2023-06-26: Withdrawn From Com
2023-06-26: Re-ref Com On Rules and Operations of the Senate
Contribute Your Insights: Add a Unique Perspective to Political Bills. Your Contribution will be Featured Below the Primary Bill, Ordered by Date Added.
No Reviews found ..